Adicet Bio Statistics Share Statistics Adicet Bio has 83.25M
shares outstanding. The number of shares has increased by 0.37%
in one year.
Shares Outstanding 83.25M Shares Change (YoY) 0.37% Shares Change (QoQ) 0.03% Owned by Institutions (%) 61.33% Shares Floating 61.92M Failed to Deliver (FTD) Shares 42,300 FTD / Avg. Volume 8.68%
Short Selling Information The latest short interest is 4.78M, so 5.74% of the outstanding
shares have been sold short.
Short Interest 4.78M Short % of Shares Out 5.74% Short % of Float 7.67% Short Ratio (days to cover) 10.39
Valuation Ratios The PE ratio is -0.72 and the forward
PE ratio is -0.8.
Adicet Bio's PEG ratio is
0.01.
PE Ratio -0.72 Forward PE -0.8 PS Ratio 0 Forward PS 10.5 PB Ratio 0.45 P/FCF Ratio -0.9 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Adicet Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 9.29,
with a Debt / Equity ratio of 0.09.
Current Ratio 9.29 Quick Ratio 9.29 Debt / Equity 0.09 Debt / EBITDA -0.16 Debt / FCF -0.18 Interest Coverage -31903.75
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-770.54K Employee Count 152 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -41.26% in the
last 52 weeks. The beta is 1.61, so Adicet Bio's
price volatility has been higher than the market average.
Beta 1.61 52-Week Price Change -41.26% 50-Day Moving Average 0.74 200-Day Moving Average 0.78 Relative Strength Index (RSI) 58.49 Average Volume (20 Days) 487,225
Income Statement
Revenue n/a Gross Profit -6.47M Operating Income -127.61M Net Income -117.12M EBITDA -110.65M EBIT -117.12M Earnings Per Share (EPS) -1.33
Full Income Statement Balance Sheet The company has 56.49M in cash and 17.23M in
debt, giving a net cash position of 39.26M.
Cash & Cash Equivalents 56.49M Total Debt 17.23M Net Cash 39.26M Retained Earnings -497.89M Total Assets 162.97M Working Capital 110.66M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -92.38M
and capital expenditures -1.12M, giving a free cash flow of -93.5M.
Operating Cash Flow -92.38M Capital Expenditures -1.12M Free Cash Flow -93.5M FCF Per Share -1.06
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ACET does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ACET is $5.5,
which is 554.8% higher than the current price. The consensus rating is "Buy".
Price Target $5.5 Price Target Difference 554.8% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 16, 2020. It was a
backward
split with a ratio of 1:7.
Last Split Date Sep 16, 2020 Split Type backward Split Ratio 1:7
Scores Altman Z-Score -5.07 Piotroski F-Score 1
